Treatment of premature labor with ritodrine: a randomized controlled study.
Twenty-nine women with premature labor were randomly assigned to a ritodrine (N = 14) or placebo (N = 15) drug group. The 2 groups were of similar age, parity, weight, gestational age, and cervical change at the onset of treatment. They were treated sequentially with intravenous, intramuscular, and oral drugs and monitored carefully during therapy. There was a significant increase in both the maternal and fetal heart rates during ritodrine treatment, and also a significant decrease in maternal blood pressure. Ritodrine-treated women often complained of palpatations. There was no significant difference in the extension of pregnancy, birth weight, or infant survival for the ritodrine group. Although the 1-minute Apgar scores in the ritodrine group were higher, the 5-minute scores were similar in both groups.
D000328:Adult; D001034:Apgar Score; D001724:Birth Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010919:Placebos; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D012312:Ritodrine / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D010919:Placebos; D011412:Propanolamines; D012312:Ritodrine